A synthetic peptide for use as a blocking control in assays to test for specificity of ARG1 antibody, Alternative Names: Arginase 1 control peptide, Arginase 1 antibody Blocking Peptide, Anti-Arginase 1 Blocking Peptide, ARG Blocking Peptide, Liver Arginase Blocking Peptide, A I Blocking Peptide, Al Blocking Peptide, ARG 1 Blocking Peptide, ARG1 Blocking Peptide, Arginase 1 Blocking Peptide, Arginase liver Blocking Peptide, Arginase type I Blocking Peptide, Arginase1 Blocking Peptide, Liver type arginase Blocking Peptide, Type I arginase Blocking Peptide
ARG1
Reaktivität: Human, Ratte, Maus
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Liver Arginase (ARG1)
(Arginase, Liver (ARG1))
Hintergrund
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. The type I isoform of ARG1, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia.